Jiangsu Bioperfectus Technologies Co., Ltd.
SHH: 688399.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Guoqiang Wang
- Employees
- 592
- Headquarters
- Taizhou, China
- IPO year
- 2019
- Market cap
- CN¥5.4B
- Website
- https://www.s-sbio.com
Loading 688399…
Loading profile data…Frequently asked questions about 688399
What does Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) do?
Jiangsu Bioperfectus Technologies Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting detectors, as well as in vitro testing services. The company was founded in 2010 and is based in Taizhou, China.
Where does 688399.SS trade?
Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) trades on the Shanghai Stock Exchange.
What sector is 688399.SS in?
Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jiangsu Bioperfectus Technologies Co., Ltd.?
Guoqiang Wang is the chief executive officer of Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS).
Where is Jiangsu Bioperfectus Technologies Co., Ltd. headquartered?
Jiangsu Bioperfectus Technologies Co., Ltd. is headquartered in China.
Does 688399.SS pay a dividend?
Yes — Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) paid a trailing twelve-month dividend of CNY 3.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688399.SS go public?
Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS) completed its initial public offering in 2019.